CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...